H.B. No. 1797 introduces new regulations regarding drug testing and prescription drug policies for employees and independent contractors of state agencies and political subdivisions in Texas, specifically concerning the medical use of low-THC cannabis and hemp. The bill establishes Chapter 621 in the Government Code, which includes definitions for terms such as "drug test," "hemp," and "low-THC cannabis." It outlines exceptions to the regulations, indicating that they do not apply to peace officers or employees subject to federal drug testing regulations.

The bill prohibits state agencies and political subdivisions from implementing drug testing policies that require employees or contractors to submit to tests for cannabinoids, establishing negative test results as a condition of employment, or restricting the use of low-THC cannabis and hemp products. Additionally, it mandates that agencies cannot inquire about an employee's use of these substances and must comply with relevant privacy laws. The legislation allows individuals to seek relief for violations, including compensatory damages and injunctive relief, and waives sovereign immunity for claims related to these provisions. The act is set to take effect on September 1, 2025.

Statutes affected:
Introduced: ()